+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glioma Treatment Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography

  • PDF Icon

    Report

  • 182 Pages
  • September 2023
  • Region: Global
  • The Insight Partners
  • ID: 5892901
Description Jump to:
The global glioma treatment market is expected to reach US$ 8,292.5 million in 2030 from US$ 4,139.6 million in 2022. The market is projected to grow with a CAGR of 9.1% from 2022 to 2030.

The market's growth is the increasing prevalence of high-grade gliomas, including aggressive brain tumors such as glioblastomas, anaplastic astrocytomas, and oligodendrogliomas. However, high treatment costs hamper the market's growth to a certain extent.

Market Opportunities of Glioma Treatment Market

Brazil, India, China, Russia, and South Africa are among the fastest-growing economies in the world. The healthcare sectors in these countries and other developing economies are projected to expand rapidly in the coming years. The expected growth is due to changes in customer demand, increased awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer treatment market is likely to grow significantly in the coming years with the proliferation of the healthcare sector.

Factors Hampering Glioma Treatment Market

Treating brain tumors can be expensive, and the high cost of treatments becomes a cause of stress and anxiety for patients. In addition to the treatment cost, people need to bear additional unplanned costs related to patient care. High medical costs compel people to discontinue their treatment plans, which may put their health at risk and lead to further costs in the future. According to the National Library of Medicine, the direct medical costs of newly diagnosed, Temozolomide-treated (TMZ) GBM are substantial in commercially insured patients, with estimated total cumulative costs of ~US$ 268,031. The healthcare costs incurred by patients with malignant brain tumors are 20 times higher than those borne by non-cancer control groups with the same demographics.

Glioma Treatment Market: Segmental Overview

The glioma treatment market is segmented based on type into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest market share in 2022. Furthermore, the segment is expected to register the highest CAGR from 2022 to 2030. An upsurge in activities to raise public awareness of this condition and its treatment, coupled with the increasing prevalence of this disease, are among the major factors fueling the glioma treatment market growth. In addition, companies in the market for the anaplastic astrocytoma segment may derive growth opportunities from growing R&D efforts and new, untapped market segments. Based on treatment, the glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. In 2022, the surgery segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030, owing to the surgery being the most preferred technique as it removes the tumor completely. Based on grade, the glioma treatment market is segmented into Low Grade and High Grade. In 2022, the high-grade segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030. Multiple research studies are underway to understand better high-grade tumors to develop more effective treatments or therapies. The glioma treatment market is segmented based on end-users into hospitals & clinics, and ambulatory care centres. In 2022, the hospital & clinics segment held the largest market share. Furthermore, the same segment is expected to anticipate growth in demand at the fastest CAGR from 2022 to 2030. Further, the increasing number of hospitals, adoption of advanced diagnostic platforms, and growing accessibility of hospitals in developing nations would offer lucrative opportunities for the growth of the glioma treatment market for the hospital segment during the forecast period.

Glioma Treatment Market: Geographical Overview

North America holds the largest share of the global glioma treatment market, whereas the Asia Pacific is the fastest-growing region in the global glioma treatment market. The market in North America is expected to grow during the forecast period, primarily driven by the increasing prevalence of brain tumors, technological advancements in glioma treatment, and the rising number of smokers. Asia Pacific registered the highest CAGR in the global glioma treatment testing market. The market in the region is expected to grow significantly in countries including China, India, and Japan in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for brain cancer treatments and the rising prevalence of brain tumors. Therefore, the region holds huge potential for the glioma treatment market players to grow during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the glioma treatment market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the glioma treatment.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global glioma treatment, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global glioma treatment trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Glioma Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Glioma Treatment Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Initiatives by Regional and State Governments to Provide Patients Access to Treatment
5.1.2 Increase in Prevalence of High-Grade Glioma
5.2 Key Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Key Market Opportunities
5.3.1 Advancements in Healthcare Sector in Emerging Economies
5.4 Future Trends
5.4.1 Surge in Drug Approvals for Glioma Treatment
5.5 Impact Analysis:
6. Glioma Treatment Market - Global Market Analysis
6.1 Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
7. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease
7.1 Overview
7.2 Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
7.3 Astrocytoma
7.3.1 Overview
7.3.2 Astrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Oligoastrocytoma
7.4.1 Overview
7.4.2 Oligoastrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Oligodendroglioma
7.5.1 Overview
7.5.2 Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type
8.1 Overview
8.2 Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
8.3 Surgery
8.3.1 Overview
8.3.2 Surgery: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Chemotherapy
8.4.1 Overview
8.4.2 Chemotherapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Radiation Therapy
8.5.1 Overview
8.5.2 Radiation Therapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade
9.1 Overview
9.2 Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
9.3 Low Grade
9.3.1 Overview
9.3.2 Low Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Grade I: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.3.2.2 Grade II: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 High Grade
9.4.1 Overview
9.4.2 High Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Grade III: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4.2.2 Grade IV: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospital & Clinics
10.3.1 Overview
10.3.2 Hospital & Clinics: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11. Glioma Treatment Market - Geographical Analysis
11.1 North America Glioma Treatment Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America Glioma Treatment Market, by Disease
11.1.4 North America Glioma Treatment Market, by Treatment Type
11.1.5 North America Glioma Treatment Market, by Grade
11.1.5.1 North America Glioma Treatment Market, by Low Grade
11.1.5.2 North America Glioma Treatment Market, by High Grade
11.1.6 North America Glioma Treatment Market, by End User
11.1.7 North America Glioma Treatment Market, by Country
11.1.7.1 US
11.1.7.1.1 US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.2 US Glioma Treatment Market, by Disease
11.1.7.1.3 US Glioma Treatment Market, by Treatment Type
11.1.7.1.4 US Glioma Treatment Market, by Grade
11.1.7.1.4.1 US Glioma Treatment Market, by Low Grade
11.1.7.1.4.2 US Glioma Treatment Market, by High Grade
11.1.7.1.5 US Glioma Treatment Market, by End User
11.1.7.2 Canada
11.1.7.2.1 Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.2 Canada Glioma Treatment Market, by Disease
11.1.7.2.3 Canada Glioma Treatment Market, by Treatment Type
11.1.7.2.4 Canada Glioma Treatment Market, by Grade
11.1.7.2.4.1 Canada Glioma Treatment Market, by Low Grade
11.1.7.2.4.2 Canada Glioma Treatment Market, by High Grade
11.1.7.2.5 Canada Glioma Treatment Market, by End User
11.1.7.3 Mexico
11.1.7.3.1 Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.2 Mexico Glioma Treatment Market, by Disease
11.1.7.3.3 Mexico Glioma Treatment Market, by Treatment Type
11.1.7.3.4 Mexico Glioma Treatment Market, by Grade
11.1.7.3.4.1 Mexico Glioma Treatment Market, by Low Grade
11.1.7.3.4.2 Mexico Glioma Treatment Market, by High Grade
11.1.7.3.5 Mexico Glioma Treatment Market, by End User
11.2 Europe Glioma Treatment Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Glioma Treatment Market, by Disease
11.2.4 Europe Glioma Treatment Market, by Treatment Type
11.2.5 Europe Glioma Treatment Market, by Grade
11.2.5.1 Europe Glioma Treatment Market, by Low Grade
11.2.5.2 Europe Glioma Treatment Market, by High Grade
11.2.6 Europe Glioma Treatment Market, by End User
11.2.7 Europe Glioma Treatment Market, by Country
11.2.7.1 UK
11.2.7.1.1 UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.1.2 UK Glioma Treatment Market, by Disease
11.2.7.1.3 UK Glioma Treatment Market, by Treatment Type
11.2.7.1.4 UK Glioma Treatment Market, by Grade
11.2.7.1.4.1 UK Glioma Treatment Market, by Low Grade
11.2.7.1.4.2 UK Glioma Treatment Market, by High Grade
11.2.7.1.5 UK Glioma Treatment Market, by End User
11.2.7.2 Germany
11.2.7.2.1 Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.2 Germany Glioma Treatment Market, by Disease
11.2.7.2.3 Germany Glioma Treatment Market, by Treatment Type
11.2.7.2.4 Germany Glioma Treatment Market, by Grade
11.2.7.2.4.1 Germany Glioma Treatment Market, by Low Grade
11.2.7.2.4.2 Germany Glioma Treatment Market, by High Grade
11.2.7.2.5 Germany Glioma Treatment Market, by End User
11.2.7.3 France
11.2.7.3.1 France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.2 France Glioma Treatment Market, by Disease
11.2.7.3.3 France Glioma Treatment Market, by Treatment Type
11.2.7.3.4 France Glioma Treatment Market, by Grade
11.2.7.3.4.1 France Glioma Treatment Market, by Low Grade
11.2.7.3.4.2 France Glioma Treatment Market, by High Grade
11.2.7.3.5 France Glioma Treatment Market, by End User
11.2.7.4 Italy
11.2.7.4.1 Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.4.2 Italy Glioma Treatment Market, by Disease
11.2.7.4.3 Italy Glioma Treatment Market, by Treatment Type
11.2.7.4.4 Italy Glioma Treatment Market, by Grade
11.2.7.4.4.1 Italy Glioma Treatment Market, by Low Grade
11.2.7.4.4.2 Italy Glioma Treatment Market, by High Grade
11.2.7.4.5 Italy Glioma Treatment Market, by End User
11.2.7.5 Spain
11.2.7.5.1 Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.2 Spain Glioma Treatment Market, by Disease
11.2.7.5.3 Spain Glioma Treatment Market, by Treatment Type
11.2.7.5.4 Spain Glioma Treatment Market, by Grade
11.2.7.5.4.1 Spain Glioma Treatment Market, by Low Grade
11.2.7.5.4.2 Spain Glioma Treatment Market, by High Grade
11.2.7.5.5 Spain Glioma Treatment Market, by End User
11.2.7.6 Rest of Europe
11.2.7.6.1 Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.2 Rest of Europe Glioma Treatment Market, by Disease
11.2.7.6.3 Rest of Europe Glioma Treatment Market, by Treatment Type
11.2.7.6.4 Rest of Europe Glioma Treatment Market, by Grade
11.2.7.6.4.1 Rest of Europe Glioma Treatment Market, by Low Grade
11.2.7.6.4.2 Rest of Europe Glioma Treatment Market, by High Grade
11.2.7.6.5 Rest of Europe Glioma Treatment Market, by End User
11.3 Asia Pacific Glioma Treatment Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific Glioma Treatment Market, by Disease
11.3.4 Asia Pacific Glioma Treatment Market, by Treatment Type
11.3.5 Asia Pacific Glioma Treatment Market, by Grade
11.3.5.1 Asia Pacific Glioma Treatment Market, by Low Grade
11.3.5.2 Asia Pacific Glioma Treatment Market, by High Grade
11.3.6 Asia Pacific Glioma Treatment Market, by End User
11.3.7 Asia Pacific Glioma Treatment Market, by Country
11.3.7.1 China
11.3.7.1.1 China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.1.2 China Glioma Treatment Market, by Disease
11.3.7.1.3 China Glioma Treatment Market, by Treatment Type
11.3.7.1.4 China Glioma Treatment Market, by Grade
11.3.7.1.4.1 China Glioma Treatment Market, by Low Grade
11.3.7.1.4.2 China Glioma Treatment Market, by High Grade
11.3.7.1.5 China Glioma Treatment Market, by End User
11.3.7.2 Japan
11.3.7.2.1 Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.2 Japan Glioma Treatment Market, by Disease
11.3.7.2.3 Japan Glioma Treatment Market, by Treatment Type
11.3.7.2.4 Japan Glioma Treatment Market, by Grade
11.3.7.2.4.1 Japan Glioma Treatment Market, by Low Grade
11.3.7.2.4.2 Japan Glioma Treatment Market, by High Grade
11.3.7.2.5 Japan Glioma Treatment Market, by End User
11.3.7.3 India
11.3.7.3.1 India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.2 India Glioma Treatment Market, by Disease
11.3.7.3.3 India Glioma Treatment Market, by Treatment Type
11.3.7.3.4 India Glioma Treatment Market, by Grade
11.3.7.3.4.1 India Glioma Treatment Market, by Low Grade
11.3.7.3.4.2 India Glioma Treatment Market, by High Grade
11.3.7.3.5 India Glioma Treatment Market, by End User
11.3.7.4 South Korea
11.3.7.4.1 South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.4.2 South Korea Glioma Treatment Market, by Disease
11.3.7.4.3 South Korea Glioma Treatment Market, by Treatment Type
11.3.7.4.4 South Korea Glioma Treatment Market, by Grade
11.3.7.4.4.1 South Korea Glioma Treatment Market, by Low Grade
11.3.7.4.4.2 South Korea Glioma Treatment Market, by High Grade
11.3.7.4.5 South Korea Glioma Treatment Market, by End User
11.3.7.5 Australia
11.3.7.5.1 Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.2 Australia Glioma Treatment Market, by Disease
11.3.7.5.3 Australia Glioma Treatment Market, by Treatment Type
11.3.7.5.4 Australia Glioma Treatment Market, by Grade
11.3.7.5.4.1 Australia Glioma Treatment Market, by Low Grade
11.3.7.5.4.2 Australia Glioma Treatment Market, by High Grade
11.3.7.5.5 Australia Glioma Treatment Market, by End User
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.2 Rest of Asia Pacific Glioma Treatment Market, by Disease
11.3.7.6.3 Rest of Asia Pacific Glioma Treatment Market, by Treatment Type
11.3.7.6.4 Rest of Asia Pacific Glioma Treatment Market, by Grade
11.3.7.6.4.1 Rest of Asia Pacific Glioma Treatment Market, by Low Grade
11.3.7.6.4.2 Rest of Asia Pacific Glioma Treatment Market, by High Grade
11.3.7.6.5 Rest of Asia Pacific Glioma Treatment Market, by End User
11.4 Middle East & Africa Glioma Treatment Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Glioma Treatment Market, by Disease
11.4.4 Middle East & Africa Glioma Treatment Market, by Treatment Type
11.4.5 Middle East & Africa Glioma Treatment Market, by Grade
11.4.5.1 Middle East & Africa Glioma Treatment Market, by Low Grade
11.4.5.2 Middle East & Africa Glioma Treatment Market, by High Grade
11.4.6 Middle East & Africa Glioma Treatment Market, by End User
11.4.7 Middle East & Africa Glioma Treatment Market, by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.1.2 Saudi Arabia Glioma Treatment Market, by Disease
11.4.7.1.3 Saudi Arabia Glioma Treatment Market, by Treatment Type
11.4.7.1.4 Saudi Arabia Glioma Treatment Market, by Grade
11.4.7.1.4.1 Saudi Arabia Glioma Treatment Market, by Low Grade
11.4.7.1.4.2 Saudi Arabia Glioma Treatment Market, by High Grade
11.4.7.1.5 Saudi Arabia Glioma Treatment Market, by End User
11.4.7.2 South Africa
11.4.7.2.1 South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.2 South Africa Glioma Treatment Market, by Disease
11.4.7.2.3 South Africa Glioma Treatment Market, by Treatment Type
11.4.7.2.4 South Africa Glioma Treatment Market, by Grade
11.4.7.2.4.1 South Africa Glioma Treatment Market, by Low Grade
11.4.7.2.4.2 South Africa Glioma Treatment Market, by High Grade
11.4.7.2.5 South Africa Glioma Treatment Market, by End User
11.4.7.3 UAE
11.4.7.3.1 UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.2 UAE Glioma Treatment Market, by Disease
11.4.7.3.3 UAE Glioma Treatment Market, by Treatment Type
11.4.7.3.4 UAE Glioma Treatment Market, by Grade
11.4.7.3.4.1 UAE Glioma Treatment Market, by Low Grade
11.4.7.3.4.2 UAE Glioma Treatment Market, by High Grade
11.4.7.3.5 UAE Glioma Treatment Market, by End User
11.4.7.4 Rest of Middle East & Africa
11.4.7.4.1 Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.4.2 Rest of Middle East & Africa Glioma Treatment Market, by Disease
11.4.7.4.3 Rest of Middle East & Africa Glioma Treatment Market, by Treatment Type
11.4.7.4.4 Rest of Middle East & Africa Glioma Treatment Market, by Grade
11.4.7.4.4.1 Rest of Middle East & Africa Glioma Treatment Market, by Low Grade
11.4.7.4.4.2 Rest of Middle East & Africa Glioma Treatment Market, by High Grade
11.4.7.4.5 Rest of Middle East & Africa Glioma Treatment Market, by End User
11.5 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Glioma Treatment Market, by Disease
11.5.4 South & Central America Glioma Treatment Market, by Treatment Type
11.5.5 South & Central America Glioma Treatment Market, by Grade
11.5.5.1 South & Central America Glioma Treatment Market, by Low Grade
11.5.5.2 South & Central America Glioma Treatment Market, by High Grade
11.5.6 South & Central America Glioma Treatment Market, by End User
11.5.6.1 South & Central America Glioma Treatment Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil Glioma Treatment Market, by Disease
11.5.6.2.3 Brazil Glioma Treatment Market, by Treatment Type
11.5.6.2.4 Brazil Glioma Treatment Market, by Grade
11.5.6.2.4.1 Brazil Glioma Treatment Market, by Low Grade
11.5.6.2.4.2 Brazil Glioma Treatment Market, by High Grade
11.5.6.2.5 Brazil Glioma Treatment Market, by End User
11.5.6.3 Argentina
11.5.6.3.1 Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina Glioma Treatment Market, by Disease
11.5.6.3.3 Argentina Glioma Treatment Market, by Treatment Type
11.5.6.3.4 Argentina Glioma Treatment Market, by Grade
11.5.6.3.4.1 Argentina Glioma Treatment Market, by Low Grade
11.5.6.3.4.2 Argentina Glioma Treatment Market, by High Grade
11.5.6.3.5 Argentina Glioma Treatment Market, by End User
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America Glioma Treatment Market, by Disease
11.5.6.4.3 Rest of South & Central America Glioma Treatment Market, by Treatment Type
11.5.6.4.4 Rest of South & Central America Glioma Treatment Market, by Grade
11.5.6.4.4.1 Rest of South & Central America Glioma Treatment Market, by Low Grade
11.5.6.4.4.2 Rest of South & Central America Glioma Treatment Market, by High Grade
11.5.6.4.5 Rest of South & Central America Glioma Treatment Market, by End User
12. Pre & Post Covid-19 Impact
12.1 Pre & Post Covid-19 Impact
13. Glioma Treatment Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Arbor Pharmaceuticals LLC
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Merck & Co Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Amgen Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Teva Pharmaceutical Industries Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Amneal Pharmaceuticals Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Karyopharm Therapeutics Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Biocon Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Arbor Pharmaceuticals, LLC
  • Merck and Co., Inc.
  • Sun Pharmaceutical Industries Ltd
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Amneal Pharmaceuticals, LLC
  • Karyopharm Therapeutics, Inc.
  • Bristol Mayers Squibb Company

Table Information

Report AttributeDetails
No. of Pages182
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 4.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.29 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Glioma Treatment Market Report 2025 - Product Image

Glioma Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glioma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Glioma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Glioma Treatment - Global Strategic Business Report - Product Image

Glioma Treatment - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Glioma Treatment Market - Global Forecast 2025-2032 - Product Image

Glioma Treatment Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Low-Grade Glioma Global Market Report 2025 - Product Image

Low-Grade Glioma Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.